EGFR and familial pancreatic carcinoma: In addition, we selected 24 targets of the kaempferol using the TCMSP database, and ascertained that anti-cancer effects of kaempferol treatment in pancreatic cancer cells were caused by the blockade of EGFR related Src, AKT, ERK1/2 signaling pathway.